{
    "nctId": "NCT02491957",
    "briefTitle": "Impact of LOFT Therapy\u2122 on Breast Cancer Survivors",
    "officialTitle": "Impact of LOFT Therapy\u2122 on Breast Cancer Survivors: A Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 15,
    "primaryOutcomeMeasure": "Feasibility of LOFT therapy in breast cancer survivors (< 3 years from diagnosis) treated with either chemotherapy and/or anti-estrogen therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with stage 0-III breast cancer within the past 3 years\n* Must have completed local therapy for their breast cancer\n* Must have received systemic therapy for their breast cancer (anti-estrogen and/or chemotherapy)\n* Chemotherapy must be complete prior to entry\n* Anti-estrogen therapy may be ongoing\n* Ambulatory without assistive devices\n* No orthopedic restrictions or neurologic deficits that would limit ability to complete the Power Protocol (based on the opinion of the investigator)\n* No requirement for supplemental O2\n* No unstable angina, regular use of nitroglycerin for exertional angina, or MI within the last 12 months\n* No local or distant recurrence of their breast cancer\n* No active lymphedema\n* No history of hemorrhagic stroke\n* No Heparin or Coumadin Use\n* No symptomatic peripheral vascular obstructions\n* No active gallbladder disease\n* No active kidney stones\n* No active gout\n* No active diverticulitis\n* No pituitary diseases or growth\n* Able to provide written informed consent and authorization for release of health information\n* Able to commit to LOFT training 2 times/week for 4 weeks\n\nExclusion Criteria:\n\n* Inability to meet one of the inclusion criteria above.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}